Compass Therapeutics, Inc. Profile Avatar - Palmy Investing

Compass Therapeutics, Inc.

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-…

Biotechnology
US, Boston [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Compass Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Compass Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Compass Therapeutics, Inc..

End of CMPX's Analysis
CIK: 1738021 CUSIP: 20454B104 ISIN: US20454B1044 LEI: - UEI: -
Secondary Listings
CMPX has no secondary listings inside our databases.